<DOC>
	<DOCNO>NCT02781597</DOCNO>
	<brief_summary>The purpose study evaluate efficacy tranexamic acid control bleed patient hemoptysis also evaluate safety tranexamic acid .</brief_summary>
	<brief_title>Efficacy Tranexamic Acid Hemoptysis</brief_title>
	<detailed_description>Hemoptysis common problem India due high incidence tuberculosis also due post tubercular sequale . Hemoptysis usually manage conservatively mild moderate case case massive hemoptysis manage definitive treatment option like vessel embolization ( bronchial/pulmonary artery ) surgery last option . Tranexamic acid antifibrinolytic use many surgery trauma patient control bleed show effective safe . The purpose study evaluate efficacy tranexamic acid patient hemoptysis control bleeding .</detailed_description>
	<mesh_term>Hemoptysis</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>1 . Acute ongoing hemoptysis 2 . Age : 18 year 1 . Pregnant females 2 . Females oral contraceptive 3 . Patients antifibrinolytics 4 . Patients know drug allergy 5 . Patients renal failure 6 . Patients require intubation study period 7 . Patients Massive hemoptysis ( &gt; 600 ml/24 hr )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Hemoptysis</keyword>
	<keyword>Tranexamic acid</keyword>
	<keyword>VAS score</keyword>
</DOC>